Gastrointestinal endoscopy in patients taking antiplatelet agents and anticoagulants: survey of ASGE members
| Autor: | Carlos E. Angueira, Mark Moore, John A. Ward, Shailesh C. Kadakia |
|---|---|
| Rok vydání: | 1996 |
| Předmět: |
Aspirin
medicine.medical_specialty medicine.diagnostic_test medicine.drug_class business.industry General surgery Anticoagulant Gastroenterology MEDLINE Warfarin Colonoscopy Endoscopy Surgery Pharmacovigilance medicine Platelet aggregation inhibitor Radiology Nuclear Medicine and imaging business medicine.drug |
| Zdroj: | Gastrointestinal Endoscopy. 44:309-316 |
| ISSN: | 0016-5107 |
| DOI: | 10.1016/s0016-5107(96)70170-0 |
| Popis: | Background: Gastrointestinal endoscopy is often required in patients taking aspirin, nonsteroidal anti-inflammatory drugs (NSAIDs), or anticoagulants. Because proper guidelines are lacking, we believe that most endoscopists use their own criteria and judgment for stopping and restarting these agents during the periendoscopic period, and the practice varies widely. The aim of our study was to identify these practices among ASGE members. Methods: Questionnaires, each containing 22 questions with 157 responses, were sent to 3300 ASGE members, including all Gastroenterology Fellowship Program Directors. One thousand two hundred sixty-nine questionnaires were received and analyzed. Results: Physicians stopped aspirin and NSAIDs more frequently before colonoscopy (81%) and ERCP (79%) than before upper endoscopy (51%) ( p p p Conclusions: We conclude that a wide variation exists regarding the management of aspirin, NSAIDs, and anticoagulants in the periendoscopic period. There is a definite need for a consensus statement or guidelines for managing patients taking these agents. (Gastrointest Endosc 1996;44:309-16.) |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect